High glycaemic variability in individuals with type 1 diabetes is associated with a reduced proportion of CD8+ TNF+ cells in response to influenza A virus

Marcus Zhen Wei Tong,Katina D. Hulme,Soi Cheng Law,Ellesandra Noye,Emily S. Dorey,Keng Yih Chew,Louise C Rowntree,Carolien E. van de Sandt,Katherine Kedzierska,Marco Goeijenbier,Katharina Ronacher,Fawaz Alzaid,Jean-Baptiste Julla,Jean-Pierre Riveline,Katie Lineburg,Corey Smith,Emma J Grant,Stephanie Gras,Linda A Gallo,Helen L Barett,Kirsty Short

DOI: https://doi.org/10.1101/2024.08.27.24311465

2024-08-28

Abstract:Objective: Diabetes mellitus significantly increases the risk of severe respiratory virus disease like influenza and COVID-19. Early evidence suggests that this susceptibility to respiratory viral disease is driven by glycaemic variability, rather than average blood glucose levels. In healthy individuals, blood glucose levels remain relatively stable throughout the day. However, in individuals living with diabetes, blood glucose spikes are more frequent and higher in magnitude. Continuous glucose monitoring (CGM) provides a unique opportunity to detect these hyper and hypoglycaemic events, even in the presence of an in range HbA1c. Research design and methods: Here, we use blood samples and CGM data obtained from people living with Type 1 diabetes (T1D) to determine the effects of glycaemic variability on the T-cell response to influenza virus.Low glycaemic variability was defined as a coefficient of variation (CV) less than 33% (n = 13) whilst high glycaemic variability was defined as a CV greater than 33% (n = 19). Results: We show that high glycaemic variability in participants living with T1D is associated with a reduced proportion of CD8 positive, TNF positive T-cells in response to stimulation with influenza virus and an influenza peptide pool.High glycaemic variability in this patient population is primarily driven by hypoglycaemic events. Conclusions: Together, this study provides the first evidence that glycaemic variability affects the T-cell response to respiratory viruses. These data suggest that monitoring glycaemic variability may have important implications in understanding the antiviral immune response in people with diabetes.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is whether high blood - glucose fluctuations affect the T - cell immune response to influenza virus in patients with type 1 diabetes. Specifically, the researchers explored the relationship between blood - glucose fluctuations and influenza - virus - specific T - cell responses by analyzing continuous glucose monitoring (CGM) data of patients with type 1 diabetes. The research hypothesized that high blood - glucose fluctuations would reduce the antiviral T - cell responses to influenza virus in these patients.

The research design includes:
- **Participant Recruitment**: 32 patients with type 1 diabetes using continuous or instantaneous blood - glucose monitoring devices were recruited.
- **Definition of Blood - glucose Fluctuations**: Participants were divided into a low - blood - glucose - fluctuation group (CV < 33%, n = 13) and a high - blood - glucose - fluctuation group (CV > 33%, n = 19) according to the coefficient of variation (CV) of blood - glucose.
- **Experimental Methods**: Blood samples and CGM data of participants were collected, and the phenotype and function of T - cells were evaluated by multiple experimental techniques (such as flow cytometry, cytokine detection, etc.).

The research results show that high blood - glucose fluctuations are associated with a reduced proportion of cells producing IFN - γ, MIP1β and TNF in CD8+ T - cells after influenza - virus stimulation. In addition, high blood - glucose fluctuations are also associated with an increased proportion of naive cells and a reduced proportion of terminally differentiated cells (TEMRA) in CD8+ T - cells.

In conclusion, this study provides the first evidence that blood - glucose fluctuations can affect the T - cell immune response to respiratory viruses in patients with type 1 diabetes, which may be of great significance for understanding the antiviral immune mechanisms in diabetic patients.